Healthy Ears: A telehealth-facilitated randomised-controlled trial utilising a health promotion intervention to resolve otitis media with effusion for children on specialist Ear, Nose and Throat (ENT) waiting lists.

Telethon Kids Institute0 个研究点目标入组 250 人开始时间: 2022年4月7日最近更新: 2023年3月13日

适应症

试验速览

暂无简介。

•1.Children aged between three years old and seven years old.
•2.Children identified during the triage of initial referral to PCH for hearing or ear-related presenting complaints.
•3.Children who have the capacity to comply with study procedures, including follow up, regardless of residential geographical location.
•4.Children who have been assessed and subsequently confirmed persistent otitis media with effusion (greater than or equal to 3 months) within a twelve month period as well as the following clinical criteria:
•a)Type B tympanometry,
•i.Unilateral or bilateral
•ii.With or without hearing loss.

•1.Children who are known to be scheduled to undergo surgical intervention within four weeks.
•2.Children who have been diagnosed with any of the following complex medical conditions which increases the risk of complications; cleft lip and palate, Down syndrome, major chromosomal anomalies, craniofacial anomalies, chronic suppurative otitis media, or congenital ear anomalies.
•3.Children who are actively participating in another ear intervention study.
•4.Children are unable to comply with relevant study procedures due to any physical, medical, developmental, behavioural or cognitive condition.
•5.Guardian(s) decline to cease the use of ear clearing devices for the four-to-six-week duration of the intervention and control, ie. ear syringe, ear candle, ear relief device (EarPopper®), over-the-counter ear drops, nasal balloon etc.
•6.The child’s legal representative is unwilling or unable to provide informed consent for the minor to participate in the study.
•7.The child does not meet the clinical inclusion criteria..

发起方